Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its ...

Activist investor Starboard Value accused Pfizer of pressuring its former CEO Ian Read and ex-CFO Frank D’Amelio to halt ...

Pfizer is facing a messy showdown this week after an outside bid to revive the company’s post-Covid share plunge took an ...

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...

GSK shares rose after the British drug major agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn medicine Zantac caused cancer. Write to Rob ...

Former Pfizer CEO Ian Read and former CFO Frank D’Amelio announced their withdrawal from Starboard Value’s activist campaign ...

As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...

Two former Pfizer executives published a statement saying they support the current company management as it gets pressured ...

Pfizer Inc.'s stock dipped 2.5% Thursday as the company's battle with activist shareholder Starboard Value heated up, after two former executives for the pharma giant said they would not support ...

Albert Bourla was preparing for a board off-site in Ireland this Sunday, when the Pfizer chief executive opened his email inbox to see an unexpected message. The email from Frank D’Amelio, his former ...

Pfizer stock skidded Thursday after former executives Ian Read and Frank D'Amelio sided with the drugmaker over activist investor Starboard.

In a letter to Pfizer’s board, the activist investor claimed former CEO Ian Read and CFO Frank D’Amelio were pressured to abandon a Starboard-led attempt to change the company’s direction.